| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ruilin Yang | Q61160462 |
| Xuhong Lin | Q91154699 | ||
| P2093 | author name string | Yao Xu | |
| Zhifeng Dai | |||
| Huichao Wang | |||
| P2860 | cites work | The Gut Microbiota in Immune-Mediated Inflammatory Diseases | Q26741414 |
| Innate Sensing of the Gut Microbiota: Modulation of Inflammatory and Autoimmune Diseases | Q26765847 | ||
| Intestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease Pathogenesis | Q26781239 | ||
| Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? | Q26828617 | ||
| Implication of the intestinal microbiome in complications of cirrhosis | Q28068832 | ||
| Gut Microbiota and Host Reaction in Liver Diseases | Q28083295 | ||
| Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury | Q28244656 | ||
| Gut Microbiota in Health and Disease | Q29616812 | ||
| Engineering the gut microbiota to treat hyperammonemia. | Q30664039 | ||
| Alterations in the gut microbiome of children with severe ulcerative colitis | Q34101549 | ||
| Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease | Q34439876 | ||
| Revised Estimates for the Number of Human and Bacteria Cells in the Body | Q34537872 | ||
| Evaluation of suitable reference genes for gene expression studies in porcine PBMCs in response to LPS and LTA. | Q34581418 | ||
| Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation | Q34649064 | ||
| Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection | Q35008279 | ||
| Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota | Q35129064 | ||
| Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis | Q35697286 | ||
| Gut microbiota modulate the immune effect against hepatitis B virus infection | Q35745517 | ||
| Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children | Q35904758 | ||
| Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease | Q35977446 | ||
| Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis. | Q36096614 | ||
| Role of intestinal microbiota and metabolites on gut homeostasis and human diseases | Q36243299 | ||
| Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line | Q36249804 | ||
| The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease | Q36310293 | ||
| Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity | Q37925064 | ||
| Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons? | Q37945301 | ||
| Microbiota in autoimmunity and tolerance | Q37960734 | ||
| Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. | Q37962297 | ||
| The impact of differential antiviral immunity in children and adults | Q38037339 | ||
| Translation inhibition and metabolic stress pathways in the host response to bacterial pathogens | Q38106599 | ||
| Innate immune responses in hepatitis B virus (HBV) infection | Q38186180 | ||
| Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses | Q38270733 | ||
| Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis | Q38308819 | ||
| Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy | Q38678789 | ||
| Mechanisms of Hepatitis B Virus Persistence | Q40077350 | ||
| Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein | Q40190769 | ||
| Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy | Q40393936 | ||
| Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients | Q44319592 | ||
| Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation | Q44751211 | ||
| Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients. | Q45973840 | ||
| Exercise has the guts: How physical activity may positively modulate gut microbiota in chronic and immune-based diseases | Q46242735 | ||
| Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients | Q47098813 | ||
| Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats | Q49898219 | ||
| Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches | Q50136712 | ||
| Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease. | Q53408592 | ||
| Help, hope and hype: ethical considerations of human microbiome research and applications. | Q54969645 | ||
| Fecal microbiota transplantation and its potential therapeutic uses in gastrointestinal disorders. | Q55241521 | ||
| Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up | Q57782781 | ||
| Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells | Q73322874 | ||
| Protective role of supplement with foreign Bifidobacterium and Lactobacillus in experimental hepatic ischemia-reperfusion injury | Q83292857 | ||
| [Advances in immunomodulation of microbial unmethylated CpG DNA on animal intestinal tract--a review] | Q85886978 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis B virus | Q6844 |
| liver | Q9368 | ||
| intestine | Q9639 | ||
| liver cirrhosis | Q147778 | ||
| immunology | Q101929 | ||
| human gut flora | Q739734 | ||
| hepatocellular carcinoma | Q1148337 | ||
| liver neoplasm | Q18558073 | ||
| chronic hepatitis B | Q55779876 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 2361963 | |
| P577 | publication date | 2018-07-25 | |
| P1433 | published in | Journal of Immunology Research | Q26841936 |
| P1476 | title | The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection | |
| P478 | volume | 2018 |
| Q99593673 | CD8 T cells drive anorexia, dysbiosis, and blooms of a commensal with immunosuppressive potential after viral infection |
| Q91936590 | Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles |
| Q89533721 | Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction |
| Q61814448 | Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature |
| Q98224235 | The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases |
| Q92005867 | γδ T-cell responses during HIV infection and antiretroviral therapy |
Search more.